Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

CDC Telebriefing: New Vital Signs Report How can expanded syringe services programs protect gains in HIV prevention?

This website is archived for historical purposes and is no longer being maintained or updated.

Media Advisory

Embargoed until: Tuesday, November 29, 2016, 2:30 PM ET
Contact: CDC Media Relations
404-639-3286

What

One consequence of the nation’s devastating opioid epidemic is the increased risk of HIV and hepatitis B and C transmission through unsafe injection drug use. Syringe services programs (SSPs) can greatly reduce that risk. This briefing will address new data on trends in SSP use and risk behavior among people who inject drugs, and concrete steps that can be taken to accelerate HIV prevention progress in this population.

Who

CDC Director Tom Frieden, M.D., M.P.H.

Jonathan Mermin, M.D., M.P.H.
Director, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention

When

Tuesday, November 29, 2016, at 2:00 p.m. ET

Dial In

Media: 888-795-0855
Non-Media: 800-369-1605
International: 1-630-395-0331
PASSCODE: CDC Media

Important Instructions 
Please dial in 10 to 15 minutes before the start of the press conference. If you would like to ask a question during the call, press *1 on your touchtone phone. Press *2 to withdraw your question. You may queue up at any time. You will hear a tone to indicate your question is pending.

Transcript
A transcript of this media availability will be available following the briefing at CDC’s web site: www.cdc.gov/media.

###
U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES

TOP